These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 811542)

  • 1. The effect of reduction and reoxidation on the biological activities and structure of human Clq (first component of complement).
    Heusser CH; Boesman M; Knobel HR; Jacot-Guillarmod H; Isliker H
    Immunochemistry; 1975 Mar; 12(3):213-9. PubMed ID: 811542
    [No Abstract]   [Full Text] [Related]  

  • 2. Cleavage products of C4b produced by enzymes in human serum.
    Shiraishi S; Stroud RM
    Immunochemistry; 1975 Dec; 12(12):935-9. PubMed ID: 815169
    [No Abstract]   [Full Text] [Related]  

  • 3. Structural studies on human Clq: non-covalent and covalent subunits.
    Yonemasu K; Stroud RM
    Immunochemistry; 1972 May; 9(5):545-54. PubMed ID: 4113858
    [No Abstract]   [Full Text] [Related]  

  • 4. Fc fragment of human immunoglobulin G: reduction and carboxymethylation of inter-chain disulfide bonds enhances complement activating capacity.
    Lopez de Castro JA; Vivanco F; Ortiz F
    Biochem Biophys Res Commun; 1977 Oct; 78(4):1319-26. PubMed ID: 921779
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitation of immune complexes by competitive inhibition of binding of Clq to insoluble IgG aggregates.
    Fletcher DS; Lin TY
    J Immunol Methods; 1977; 15(1):39-45. PubMed ID: 845441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of C-reactive protein with the first component of human complement.
    Claus DR; Siegel J; Petras K; Osmand AP; Gewurz H
    J Immunol; 1977 Jul; 119(1):187-92. PubMed ID: 17637
    [No Abstract]   [Full Text] [Related]  

  • 7. The structure and mechanism of activation of the first component of complement.
    Reid KB; Porter RR
    Contemp Top Mol Immunol; 1975; 4():1-22. PubMed ID: 1104255
    [No Abstract]   [Full Text] [Related]  

  • 8. The inactivator of the first component of human complement (C1INA). The complex formation with the activated first component of human complement (C1) or with its subcomponents.
    Nagaki K; Iida K; Inai S
    Int Arch Allergy Appl Immunol; 1974; 46(6):935-48. PubMed ID: 4210434
    [No Abstract]   [Full Text] [Related]  

  • 9. Clq production and secretion by fibroblasts.
    Al-Adnani MS; McGee JO
    Nature; 1976 Sep; 263(5573):145-6. PubMed ID: 967248
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.
    Zubler RH; Lange G; Lambert PH; Miescher PA
    J Immunol; 1976 Jan; 116(1):232-5. PubMed ID: 1245740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic digestion of the first component of human complement (C1q).
    Knobel HR; Heusser C; Rodrick ML; Isliker H
    J Immunol; 1974 Jun; 112(6):2094-101. PubMed ID: 4363509
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alternate complement pathway in Behçet disease (author's transl)].
    Kogure M; Ono Y
    Nippon Ganka Gakkai Zasshi; 1975 Mar; 79(3):172-6. PubMed ID: 1171606
    [No Abstract]   [Full Text] [Related]  

  • 13. Further studies on the identification of the subcomponents of the first component of complement after affinity chromatography of human serum on IgG-sepharose.
    Taylor PA; Fink S; Bing DH; Painter RH
    J Immunol; 1977 May; 118(5):1722-7. PubMed ID: 858917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative binding of a complement component to antigen-antibody complexes. III. Complexes containing IgM antibodies.
    Kuo CY; Thompson JJ; Hoffmann LG
    Z Immunitatsforsch Immunobiol; 1976 Sep; 152(2):151-66. PubMed ID: 960974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.
    Teshima H; Wanebo H; Pinsky C; Day NK
    J Clin Invest; 1977 Jun; 59(6):1134-42. PubMed ID: 325016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure and activation of the early components of complement.
    Porter RR
    Fed Proc; 1977 Aug; 36(9):2191-6. PubMed ID: 328305
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultracentifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement.
    Schumaker VN; Calcott MA; Spiegelberg HL; Müller-Eberhard HJ
    Biochemistry; 1976 Nov; 15(23):5175-81. PubMed ID: 990273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venom of the ant Pseudomyrmex sp.: further characterization of two factors that affect human complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1977 Nov; 119(5):1690-9. PubMed ID: 410881
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemistry of complement.
    Porter RR
    Ric Clin Lab; 1977; 7(3):191-7. PubMed ID: 605337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.